Treatment of infantile colic with dicyclomine hydrochloride.

We performed a prospective, randomized, double-blind, placebo-controlled clinical trial of dicyclomine hydrochloride using specific diagnostic criteria for infantile colic: spells of unexplained irritability, agitation, fussiness or crying lasting greater than or equal to 3 hours/day, occurring greater than or equal to 3 days/week, and continuing for greater than or equal to 3 weeks. Dicyclomine eliminated colic in 15 of 24 (63%) infants, whereas placebo was effective in six of 24 (25%) (corrected X2 = 5.42, P = 0.02). The study also addressed the hypothesis that parental distress caused by infantile colic affects subsequent temperament and sleep patterns. The data fail to document easier temperaments or longer sleep durations at 4 months in infants whose colic ceased during treatment.
AuthorsM Weissbluth, K K Christoffel, A T Davis
JournalThe Journal of pediatrics (J Pediatr) Vol. 104 Issue 6 Pg. 951-5 (Jun 1984) ISSN: 0022-3476 [Print] United States
PMID6374085 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cyclohexanecarboxylic Acids
  • Dicyclomine
  • Clinical Trials as Topic
  • Colic (drug therapy)
  • Cyclohexanecarboxylic Acids (therapeutic use)
  • Dicyclomine (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Male
  • Parent-Child Relations
  • Prospective Studies
  • Random Allocation
  • Sleep (drug effects)
  • Temperament (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: